Ryvu Therapeutics is a series b startup. 1 investor tracked on Brouky Intelligence. Status: possibledead. Data sourced from Brouky Intelligence.
About
Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel small molecule therapies that address unmet medical needs in oncology.
Stage
series-b
Investors
1
See full investor history, risk signals & comparable companies
Brouky tracks 15,000+ startups with funding rounds, risk analysis, and AI-powered investor matching.
Subscribe to Brouky